Ukko
On a mission to solve food allergies and sensitivities
United States · $85.0M raised
- Employees
- 11–50
- Business Model
- B2B
- Website
- ukko.us
- Total Funding
- $85.0M
- Last Round
- $45.0M Series CJan 2026
- Rounds
- 2
About
Biotechnology company designing immunotherapies for food allergies and sensitivities using machine learning and protein engineering.
Summary
Ukko is a Biotech company based in United States. It has raised $85.0M in total across 2 rounds, most recently a $45.0M Series C round in Jan 2026. Investors include Leaps by Bayer, Israel Biotech Fund and Khosla Ventures.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jan 2026
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...